Companies to automate a critical step of
high-throughput single-cell multiomics experiments
FRANKLIN
LAKES, N.J., Jan. 23,
2024 /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX), a leading global medical technology company,
announced a collaboration agreement with Hamilton, a leading global
manufacturer of laboratory automation technology, to develop
automated applications together with robotics-compatible reagent
kits to enable greater standardization and reduced human error when
conducting large-scale single-cell multiomics experiments.
As a result of the collaboration, BD aims to deliver a suite of
BD Rhapsody™ Single-Cell Analysis Library Preparation Reagent Kits
that can be performed on the Hamilton Microlab® NGS STAR™ robotic
liquid-handling platform. The combination will automate steps,
including pipetting and thermal cycling, to produce DNA samples or
"libraries" that are ready for genetic sequencing.
In single-cell multiomics experiments, constructing libraries of
fragmented genetic information that can be read by sequencing
instruments is an essential first step before next-generation
sequencing (NGS) can be performed and insights from cells can be
gathered. NGS library preparation is historically a time-intensive
process with manual steps that can result in inconsistent results
and compromised data quality.
"Multiomics-based assays are increasingly used by single cell
researchers in the fields of oncology, immunology and other
disciplines to help investigate the various layers of information
on a single cell and access a deeper view of health and disease,
which is why ensuring reproducible results is critical," said
Steve Conly, worldwide president at
BD Biosciences. "By integrating Hamilton's robotic technology into
our end-to-end portfolio of single-cell multiomics solutions, BD
continues to leverage automation so that more researchers — whether
academic, biopharmaceutical, or contract research organization— are
empowered to perform larger scale single-cell multiomics studies
with confidence."
Matt Hamilton, Vice CEO at
Hamilton added, "Through this collaboration with BD, we aim to
deliver a complete solution for researchers that reduces the
potential for biases and enables greater throughput so that labs
can achieve their results with greater reliability. As more
researchers adopt the rapidly evolving and important approach of
single-cell multiomics, we believe that having automated solutions
for high-throughput experiments will serve to accelerate their
potentially life-changing discoveries."
The BD Rhapsody™ Single-Cell Analysis Library Preparation
Reagent Kits and Hamilton Microlab® NGS STAR™ applications will be
developed and released in phases starting in 2024.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its more than
70,000 employees have a passion and commitment to help enhance the
safety and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please visit
bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or
Instagram @becton_dickinson.
Contacts:
|
|
|
|
Media:
|
Investors:
|
Troy
Kirkpatrick
|
Adam Reiffe
|
VP, Public
Relations
|
Sr. Director, Investor
Relations
|
858.617.2361
|
201.847.6927
|
troy.kirkpatrick@bd.com
|
adam.reiffe@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-hamilton-collaborate-to-standardize-single-cell-multiomics-experiments-using-robotics-302041302.html
SOURCE BD (Becton, Dickinson and Company)